VAN HOOSE KYRI K. (Chief Financial Officer) received a stock award from DERMATA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/18/2026ACC: 0001493152-26-039046
Officer· Chief Financial Officer
Since Sep 2021
+306.12K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
306.12K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+102.04K
Price / share
—
Trade value
—
% of position
78.2%
8/16/2026
130.42K→232.46K
Total
Net shares
+102.04K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/16/2026 | A · Award | +102.04K | — | — | 78.2% | 130.42K | 232.46K |
| Total | +102.04K | $0.00 | ||||||
Derivative Transactions2
Series E Warrant (Right to Buy)
Direct
Converts to
Common Stock
102.04K shares
Shares
+102.04K
Strike price
1.47
Held after
102.04K
Exercisable
—
8/16/2026
Series F Warrant (Right to Buy)
Direct
Converts to
Common Stock
102.04K shares
Shares
+102.04K
Strike price
1.47
Held after
102.04K
Exercisable
—
8/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series E Warrant (Right to Buy) Direct | Common Stock102.04K shares | 8/16/2026 | A · Award | +102.04K | 1.47 | — | 102.04K |
| Series F Warrant (Right to Buy) Direct | Common Stock102.04K shares | 8/16/2026 | A · Award | +102.04K | 1.47 | — | 102.04K |